This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. Living with multiple sclerosis…
Four people living with cognitive decline share their stories. Below, Being Patient features — in a series of short-form documentary videos — people diagnosed…
For people living with TBI, articulating what is happening inside the brain can be challenging. Daniel Avesar went so far as to get a…
One morning, Lori noticed her husband, Bob, couldn’t form a sentence — he was having a stroke. He was diagnosed with MCI due to…
When retired interior designer Denis Lowe began to have problems with multitasking and presenting designs to clients, he knew something was wrong. Three years…
Brain Talk, hosted by Being Patient founder Deborah Kan and journalist Mark Niu, digs into the topics that matter most to the Being Patient…
ApoE4, a genetic variation sometimes referred to as the “Alzheimer’s gene,” is one of the most influential genetic risk factors for developing Alzheimer’s disease….
Imagine being diagnosed with Alzheimer’s in your early 60s and leaving your career, only to find out years later that you had no signs…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. For many people, when…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. In the newest definition…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. Creativity can flourish for…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. When you’re concerned about…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. What would you do…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. For 25 years, Mark…
In February, Biogen announced it was pulling Aduhelm off the market. The company will continue supplying the drug until November but stopped providing it…